Study Group: Urologists (EU)(?)

Both lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) have a high prevalence among aging men, and their occurrence increases at a similar rate. Sexual dysfunction is strongly related to the severity of LUTS, and researchers are now investigating...

This drug only shows that it retards prostate growth, not that it shrinks the gland. Finasteride and dutasteride actually shrink he prostate and much quicker also.  The improvements in symptom scores and flow rates, although statistically significant, will make absolutely no difference in...

This article is too flawed from the outset for it to be used as constructive evidence in the debate as to whether surgery or radiotherapy is better for treatment of prostate cancer.  Its core message is being publishised in the media without even the authors' own warnings as to its applicability...

The phase 2 trial data presents results with a better outcome for superficial bladder cancer patients as those treated with standard procedures. A complete remission result after 2 years of 67% is dramatically better then adjuvant Chemoinstillation of immune therapy by BCG. The most important question...

This is encouraging news in a disease process that is very debilitating and fatal, with huge co-morbidity.  The use of an oral agent is of course a huge step forward.  Although at very early stages, this is a very exciting development.  The introduction of a phase 3...